Continental Advisors Llc decreased its stake in Myriad Genetics Inc (MYGN) by 41.43% based on its latest 2017Q3 regulatory filing with the SEC. Continental Advisors Llc sold 24,900 shares as the company’s stock rose 13.21% with the market. The hedge fund held 35,200 shares of the health care company at the end of 2017Q3, valued at $1.27 million, down from 60,100 at the end of the previous reported quarter. Continental Advisors Llc who had been investing in Myriad Genetics Inc for a number of months, seems to be less bullish one the $2.27 billion market cap company. The stock decreased 1.25% or $0.41 during the last trading session, reaching $32.42. About 440,565 shares traded. Myriad Genetics, Inc. (NASDAQ:MYGN) has declined 37.47% since March 1, 2017 and is downtrending. It has underperformed by 54.17% the S&P500.
Princeton Portfolio Strategies Group Llc increased its stake in Henry Schein Inc (HSIC) by 96.63% based on its latest 2017Q3 regulatory filing with the SEC. Princeton Portfolio Strategies Group Llc bought 10,161 shares as the company’s stock rose 5.77% with the market. The institutional investor held 20,676 shares of the health care company at the end of 2017Q3, valued at $1.70 million, up from 10,515 at the end of the previous reported quarter. Princeton Portfolio Strategies Group Llc who had been investing in Henry Schein Inc for a number of months, seems to be bullish on the $10.17B market cap company. The stock decreased 1.52% or $1.02 during the last trading session, reaching $66.19. About 1.36 million shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has risen 4.05% since March 1, 2017 and is uptrending. It has underperformed by 12.65% the S&P500.
Among 21 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Henry Schein Inc. had 46 analyst reports since July 31, 2015 according to SRatingsIntel. Piper Jaffray maintained Henry Schein, Inc. (NASDAQ:HSIC) on Thursday, February 11 with “Neutral” rating. The company was maintained on Thursday, November 5 by RBC Capital Markets. Goldman Sachs upgraded the shares of HSIC in report on Tuesday, October 11 to “Buy” rating. Robert W. Baird upgraded the shares of HSIC in report on Tuesday, January 3 to “Outperform” rating. The rating was downgraded by Northcoast to “Neutral” on Tuesday, December 6. Leerink Swann maintained Henry Schein, Inc. (NASDAQ:HSIC) on Wednesday, February 21 with “Market Perform” rating. On Tuesday, August 8 the stock rating was maintained by Stifel Nicolaus with “Hold”. The firm has “Hold” rating by Jefferies given on Tuesday, November 7. On Tuesday, November 28 the stock rating was maintained by Credit Suisse with “Hold”. The stock has “Neutral” rating by Robert W. Baird on Friday, October 14.
Since September 6, 2017, it had 0 buys, and 1 sale for $366,756 activity.
Investors sentiment increased to 7.15 in 2017 Q3. Its up 5.99, from 1.16 in 2017Q2. It improved, as 47 investors sold HSIC shares while 15 reduced holdings. 66 funds opened positions while 377 raised stakes. 279.70 million shares or 306.41% more from 68.82 million shares in 2017Q2 were reported. Axa accumulated 101,768 shares or 0.04% of the stock. Moreover, Tudor Investment Et Al has 0.02% invested in Henry Schein, Inc. (NASDAQ:HSIC). 2,828 were reported by Glenmede Tru Co Na. Wealth Enhancement Advisory invested 0.07% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Silvercrest Asset Mngmt Gru Ltd Llc holds 108,582 shares. Baldwin Brothers Inc Ma, Massachusetts-based fund reported 17,435 shares. Oppenheimer Asset Mgmt holds 44,563 shares or 0.09% of its portfolio. M&T National Bank holds 23,466 shares or 0.01% of its portfolio. Select Equity Grp Inc Limited Partnership reported 476,491 shares. Royal Savings Bank Of Canada holds 0.01% or 374,860 shares. Highland Capital Management Ltd Liability owns 6,009 shares. Parametric Associates Ltd Company stated it has 0.04% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Btim accumulated 2,850 shares or 0% of the stock. Netherlands-based Pensionfund Dsm Netherlands has invested 0.45% in Henry Schein, Inc. (NASDAQ:HSIC). 20 were reported by Baystate Wealth Mngmt Limited Com.
Princeton Portfolio Strategies Group Llc, which manages about $199.15M and $369.47 million US Long portfolio, decreased its stake in American Tower Corp Class (NYSE:AMT) by 2,795 shares to 54,150 shares, valued at $7.40 million in 2017Q3, according to the filing. It also reduced its holding in Nextera Energy Inc (NYSE:NEE) by 21,602 shares in the quarter, leaving it with 30,397 shares, and cut its stake in Automatic Data Processing (NASDAQ:ADP).
Analysts await Myriad Genetics, Inc. (NASDAQ:MYGN) to report earnings on May, 1. They expect $0.27 earnings per share, 0.00% or $0.00 from last year’s $0.27 per share. MYGN’s profit will be $18.86 million for 30.02 P/E if the $0.27 EPS becomes a reality. After $0.31 actual earnings per share reported by Myriad Genetics, Inc. for the previous quarter, Wall Street now forecasts -12.90% negative EPS growth.
Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.16, from 1.02 in 2017Q2. It turned negative, as 33 investors sold MYGN shares while 72 reduced holdings. 28 funds opened positions while 62 raised stakes. 71.79 million shares or 8.95% less from 78.85 million shares in 2017Q2 were reported. Camber Cap Ltd reported 4.59% stake. Northern Trust Corp has 0.01% invested in Myriad Genetics, Inc. (NASDAQ:MYGN) for 1.53 million shares. Tocqueville Asset Mgmt Limited Partnership reported 35,099 shares. The Japan-based Mitsubishi Ufj Tru And Bk Corporation has invested 0.03% in Myriad Genetics, Inc. (NASDAQ:MYGN). 779,281 are owned by Pinnacle Assoc Limited. Huntington Retail Bank owns 221 shares. Citigroup reported 99,131 shares stake. State Board Of Administration Of Florida Retirement System reported 93,923 shares. Sei Invs Company invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). Ingalls & Snyder Limited Liability Corporation owns 53,599 shares or 0.1% of their US portfolio. Missouri-based American Century Cos has invested 0% in Myriad Genetics, Inc. (NASDAQ:MYGN). State Of Tennessee Treasury Department holds 0.01% of its portfolio in Myriad Genetics, Inc. (NASDAQ:MYGN) for 60,266 shares. Cibc Asset Mgmt Inc, a Ontario – Canada-based fund reported 8,559 shares. 48,710 are held by Ghp Advisors. Gsa Prtnrs Llp reported 73,000 shares.
Continental Advisors Llc, which manages about $318.00M and $437.12 million US Long portfolio, upped its stake in Price T Rowe Group Inc (NASDAQ:TROW) by 8,000 shares to 95,000 shares, valued at $8.61M in 2017Q3, according to the filing. It also increased its holding in Santander Consumer Usa Hdg I (NYSE:SC) by 324,081 shares in the quarter, for a total of 474,081 shares, and has risen its stake in Vitamin Shoppe Inc (NYSE:VSI).
Since September 1, 2017, it had 0 buys, and 7 insider sales for $5.48 million activity. 30,000 shares valued at $909,040 were sold by HENDERSON JOHN T on Friday, September 1. 37,654 shares were sold by MARSH RICHARD M, worth $1.52 million. 6,000 Myriad Genetics, Inc. (NASDAQ:MYGN) shares with value of $201,000 were sold by DREISMANN HEINRICH. GILBERT WALTER PHD also sold $248,925 worth of Myriad Genetics, Inc. (NASDAQ:MYGN) shares.
Among 20 analysts covering Myriad Genetics (NASDAQ:MYGN), 4 have Buy rating, 5 Sell and 11 Hold. Therefore 20% are positive. Myriad Genetics had 58 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, January 22 by Barclays Capital. Jefferies maintained it with “Hold” rating and $2100 target in Monday, June 12 report. The company was upgraded on Wednesday, February 8 by Ladenburg Thalmann. The stock of Myriad Genetics, Inc. (NASDAQ:MYGN) earned “Buy” rating by Gabelli on Tuesday, July 21. The rating was upgraded by Deutsche Bank on Friday, August 18 to “Hold”. On Friday, October 6 the stock rating was maintained by Morgan Stanley with “Underweight”. On Monday, August 14 the stock rating was maintained by Cowen & Co with “Hold”. Morgan Stanley maintained Myriad Genetics, Inc. (NASDAQ:MYGN) rating on Wednesday, February 7. Morgan Stanley has “Underweight” rating and $28 target. The rating was upgraded by Goldman Sachs to “Neutral” on Tuesday, December 8. The firm has “Hold” rating given on Friday, September 15 by Cowen & Co.
The post Continental Advisors Cut Myriad Genetics (MYGN) Stake as Share Price Rose; As Henry Schein (HSIC) Valuation Rose, Princeton Portfolio Strategies Group Boosted Stake by $823,041 appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/03/01/continental-advisors-cut-myriad-genetics-mygn-stake-as-share-price-rose-as-henry-schein-hsic-valuation-rose-princeton-portfolio-strategies-group-boosted-stake-by-823041/
No comments:
Post a Comment